Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation

Author： Uglietti Alessia   Zanaboni Domenico   Gnarini Mariarosaria   Maserati Renato  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.8, Iss.10, 2012-10, pp. : 1305-1314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emtricitabine/Tenofovir Disoproxil Fumarate: In Combination with a Protease Inhibitor in HIV-1 Infection

By Perry Caroline M.  

Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. : 843-857

Adis International

Access to resources Recommend Favorite

A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate

By Clercq Erik De  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2935-2937

Informa Healthcare

Access to resources Recommend Favorite

Emtricitabine/Tenofovir Disoproxil Fumarate

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 3, 2004-01 ,pp. : 160-161

Adis International

Access to resources Recommend Favorite

Emtricitabine/Tenofovir Disoproxil Fumarate

By Toni M. Dando   Antona J. Wagstaff  

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 2075-2082

Adis International

Access to resources Recommend Favorite

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Atripla®): A Review of its Use in the Management of HIV Infection

By Deeks Emma D.   Perry Caroline M.  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2315-2338

Adis International

Access to resources Recommend Favorite